BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
47 hedge funds and large institutions have $2.19M invested in BRAINSTORM CELL THERAPUTC in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more ownership
Funds ownership: 0.55% → 0.55% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Holders
47
Holding in Top 10
–
Calls
$66K
Puts
$1K
Top Buyers
| 1 | +$63K | |
| 2 | +$45.8K | |
| 3 | +$13K | |
| 4 |
Jane Street
New York
|
+$10.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$3.73K |
Top Sellers
| 1 | -$35.5K | |
| 2 | -$19K | |
| 3 | -$12.6K | |
| 4 |
Barclays
London,
United Kingdom
|
-$6K |
| 5 |
ZIG
Zullo Investment Group
Scranton,
Pennsylvania
|
-$4.4K |